Abstract: A series of new benzophenone and diphenylmethane halophenol derivatives were prepared. Their structures were established based on 1 H NMR, 13 C NMR and HRMS data.
Introduction
Protein tyrosine kinases (PTKs), which are members of a large family of oncoproteins and proto-oncoproteins, play a major role in mitogenic signal transduction, and are involved in the control of cell proliferation, differentiation and transformation. Continuing activation of PTK is associated with proliferative disorders such as cancer; hence, PTK inhibitors have been developed as molecular-targeting cancer therapeutic agents. The discovery and development of PTK inhibitors as new cancer therapeutic agents have now attracted much attention [1] [2] [3] [4] [5] [6] [7] [8] [9] . To date, many PTK inhibitors with potent activities have already passed or are currently in clinical trials to investigate their applicability as anti-cancer drugs [10] .
Various structural halophenols isolated from biologically active natural products such as various marine algae, ascidians and sponges present a wide spectrum of bioactivities including protein tyrosine phosphatase (PTP1B) inhibitory [11] , antioxidative [12, 13] , antithrombotic [14] , antimicrobial [15, 16] , anti-inflammatory [17] , enzyme inhibitory [18] , cytotoxic [19] , and appetite suppressant [20] , PTK inhibitory activities [21] . However, to the best of our knowledge, very little is known about the inhibitory activity of benzophenone and diphenylmethane halophenols against PTK, and their corresponding structure-activity relationships (SARs) have been rarely reported, despite the fact that several natural diphenylmethane bromophenols isolated from the brown alga Leathesia nana have been reported to show moderate inhibitory activity against PTK with over-expression of c-kit [21] , which reveals that diphenylmethane halophenols may possess potential significant PTK inhibitory activity.
We therefore designed and synthesized a series of new diphenylmethane and benzophenone halophenol derivatives by modification of the linker (illustrated in Table 1 ), functional groups, and substituted positions at the phenyl ring to find novel structural halophenol derivatives with strong PTK inhibitory activity, and tried to establish the SAR on the basis of this new compound library. In our previous study [22] , a series of bromo-and chloro-substituted halophenols were reported for their significant in vitro antioxidative and cytoprotective activities. However, the PTK inhibitory activity has not been evaluated. In the continued efforts towards discovering potent PTK inhibitors, a series of new fluoro-and iodo-functionalized benzophenone and diphenylmethane halophenols derivatives were also prepared and screened for their in vitro PTK inhibitory activity with genistein as positive control [23, 24] , in accordance with the fact that inclusion of F or I atoms in a compound may have profound effects on drug disposition [25] [26] [27] [28] [29] [30] . The results provide some clear and useful information about recognition of the SAR.
Results and Discussion

Chemistry
A series of new benzophenone and diphenylmethane halophenol derivatives with several groups substituted at different positions on the phenyl ring were synthesized to determine how the substituents affect the PTK inhibitory activity. Halophenol compounds 5c-13c and 5d-13d were prepared in our previous study [22] . In the present study, 12 fluoro-and four iodo-functionalized halophenol derivatives (1a-4d) were also prepared (Scheme 1), including 11 new compounds 1b, 1c, 1d, 2b, 2c, 2d, 3b, 3d, 4b, 4c and 4d. Scheme 1. Synthesis of benzophenone and diphenylmethane halophenol derivatives. Reagents and conditions: (a) AlCl 3 /CH 2 Cl 2 , rt, 4 h; (b) LiAlH 4 /AlCl 3 /ether, 40 °C, refluxed for 2 h; (c) BBr 3 /CH 2 Cl 2 (1/9, v/v) was added to the solution at −78 °C, warmed to room temperature and stirred for 2 h. 
In vitro PTK Inhibitory Activity
The in vitro PTK inhibitory activity of the prepared compounds listed in Table 1 
SAR Analysis
Diphenylmethane halophenols 7d, 8d, 9d, 10d, 11d and 13d displayed higher activities with IC 50 values of 6.34, 14.8, 12.9, 6.97, 6.26 and 5.05 μM than those of corresponding benzophenone halophenols 7c, 8c, 9c, 10c, 11c and 13c. Bromophenols 7c and 13c, which are isomers, showed no activity. Isomers of chlorophenols 8c, 9c, 10c and bromophenol 11c exhibited moderate activity with IC 50 values of 17.7, 17.8, 41.6 and 16.0 μM, respectively. Replacement of the methylene group by a carbonyl group, except 6c which showed similar activity to 6d, led to an obvious decrease, even complete disappearance of the activity, which suggested that the methylene group may greatly contribute to the PTK inhibitory activity.
Meanwhile, substitution of the hydroxyl groups by methoxyl groups resulted in the disappearance of activity, and indeed, none of the compounds with methoxyl groups on the phenyl ring showed any activity with IC 50 value higher than 50 μM. This indicated that the methoxyl group exerted a great negative effect on the PTK inhibitory activity, and also illustrated that the hydroxyl groups were essential. It is implied that these active halophenols as hydrogen donors could have key interactions with PTK.
By comparing the activities of the halogen-substituted compounds 5c, 6c, 5d and 6d, which possessed five hydroxyls and two halogen atoms at the same positions, we found that the chlorophenol compounds 6c and 6d exhibited the strongest activities with IC 50 values of 2.97 μM and 3.96 μM, respectively. However, the bromophenols 5c and 5d showed no activity. Moreover, for all of the fluoro-and iodo-functionalized halophenols, no activity was observed. Hence, the halogen atoms on the phenyl ring contributed to the activity in the order of Cl > Br > F (or I), which suggested that the chloro atom may play a pivotal role between the interaction of active halophenols and PTK. The results also showed that an increased number of hydroxyl groups and chloro atoms may be beneficial to the activity.
Compounds 8c and 9c with a chloro atom at the ortho-and meta-position of the carbonyl group exhibited moderate activities, with IC 50 values of 17.7 μM and 17.8 μM, respectively. Compound 10c with a chloro atom at the para-position of the carbonyl group showed weak activity, with an IC 50 value of 41.6 μM. Compounds 10d and 9d, with a chloro atom at the para-and meta-position of the methene group, showed high activities with IC 50 values of 6.97 μM and 12.9 μM, respectively. Compound 8d with a chloro atom at the ortho-position of the methene group exhibited identical activity with an IC 50 value of 14.8 μM, compared to that of the positive control compound (IC 50 = 13.6 μM). To the isomers of these chlorophenols, the chloro atom substituted at different position on the phenyl ring had significant effects on the activity. In addition, the same substituted position of the chloro atom on the phenyl ring had an entirely different effect on the activity of benzophenone and diphenylmethane halophenols. The results indicated that the linker and halogen had a combined influence on the activity.
The activities of compounds 12c and 12d were not enhanced by the increased number of halogen atoms. The bromophenols 11c and 11d substituted by one bromo atom obviously showed better activities than those of bromophenols 12c and 12d with two bromo atoms at the same phenyl ring.
Experimental Section
General
Melting points were taken on a micromelting point apparatus, which were uncorrected. 1 H and 13 C NMR spectra were recorded with a Bruker-AV 400 spectrometer at 400 and 100 MHz respectively, in CDCl 3 , DMSO-d 6 or CD 3 OD with TMS as reference. Chemical shifts (δ values) and coupling constants (J values) were given in ppm and Hz, respectively. ESI mass spectra were obtained on an API QTRAP 3200 MS spectrometer, and HRMS were recorded on a Bruker Daltonics Apex IV 70e FTICR-MS (Varian 7.0T).
Ether was distilled from sodium benzophenone ketyl. Dichloromethane was distilled from calcium hydride. Other reagents and solvents were commercially available unless otherwise indicated.
Typical Procedures for the Preparation of Halophenol Derivatives
The general procedures for compounds 5c-13c, and 5d-13d have been reported in our earlier study [22] . A series of new fluoro-and iodo-functionalized compounds were prepared according to the following general procedures.
Preparation of compounds 1a-4a
2-fluoro-3',4'-dimethoxyl benzophenone (1a): 2-Fluorobenzoyl chloride (10 mL, 82.2 mmol) was added at 0 °C to a solution that contained 1,2-dimethoxybenzene (10 mL, 78.5 mmol) in dried CH 2 Cl 2 (60 mL). Anhydrous AlCl 3 (11.1 g, 83.2 mmol) was added by portion wise. The mixture was allowed to warm to room temperature and stirred for 4 h, then ice-water (100 mL) was added to the mixture. The organic phase was separated, washed with water (50 mL) and dried over anhydrous Na 2 SO 4 . The solvent was evaporated under reduced pressure, and the crude product was recrystallized from methanol to give compound 1a as a white powder in 73% yield. Compounds 2a-4a were prepared in the similar manner as described for 1a. 
3-fluoro-3',4'-dimethoxyl benzophenone
The Preparation of Compounds 1b-4b
2-fluoro-3',4'-dimethoxyl diphenylmethane (1b): Anhydrous AlCl 3 (2.00 g, 15.0 mmol) and LiAlH 4 (1.00 g, 26.4 mmol) were slowly added to dried ether (50 mL). After stirring for 5 min, compound 1a (2.00 g, 7.69 mmol) was dissolved in dried ether (10 mL) and dropwisely added to the solution. The mixture was warmed to 40 °C , refluxed for 2 h, then cooled and quenched with 50 mL 18% aqueous HCl. The organic phase was separated. The water layer was extracted twice with ethyl acetate (2 × 30 mL). The combined organics were washed to neutral with water, dried over anhydrous Na 2 SO 4 , and then concentrated via rotary evaporation. The crude product was purified by silica gel chromatography with ethyl acetate-petroleum ether (1/9) as eluent to afford compound 1b. The product was recrystallized from methanol to give a white powder in 40% yield. mp 51-52 °C; 1 Compounds 2b-4b were prepared in the similar manner as described for 1b. 
3-fluoro-3',4'-dimethoxyl diphenylmethane
The Preparation of Compounds 1c-4c
2-fluoro-3',4'-dihydroxyl benzophenone (1c):
Ten milliliters BBr 3 solution (BBr 3 /CH 2 Cl 2 , v/v, 1/9) was dropwisely added to a cooled (-78 °C) solution of compound 1a (500 mg, 1.92 mmol) in dried CH 2 Cl 2 (20 mL). The mixture was warmed to room temperature, stirred for 2 h, and poured into ice-water (50 mL). The organic phase was separated. The water layer was extracted twice with ethyl acetate (2 × 20 mL). The combined organics were washed with 20 mL water, dried over anhydrous Na 2 SO 4 and concentrated via rotary evaporation. The crude product was purified by silica gel chromatography with ethyl acetate-petroleum ether (1/4, containing 1 mL acetic acid in 100 mL elution solvent) as eluent to afford compound 1c as a white powder in 53% yield. Compounds 2c-4c were prepared in the similar manner as described for 1c. Compounds 2d-4d were prepared in the similar manner as described for 1d. 
3-fluoro-3',4'-dihydroxyl benzophenone
3-fluoro-3',4'-dihydroxyl diphenylmethane
Pharmacology
After removal of the male mouse (SD) meninges, the brain was weighted and homogenized with a glass homogenizer in four volumes of cold medium (containing 20 mmol/L Tris-HCl, pH 7.5, 0.25 mol/L sucrose, 2 mmol/L DDT, 2 mmol/L EDTA, 2 mmol/L Na 3 VO 4 , 1 mmol/L DMSF, 215 mg/L aprotinin, 1 mg/L PTIFtatin, 5 mg/L leupeptin) at high speed. The mixture was centrifuged for 10 min at 1000 × g at 4 °C; the supernatant was collected and re-centrifuged for 10 min at 10,000 × g at 4 °C to obtain the target supernatant. The target supernatant that contained cytoplasmic tyrosine kinase was collected, separately packed and stored at -70 °C.
PTK activity was determined by the ELISA method. In brief, the concentrations of PTKs used to construct calibration curves were as follows: 600, 500, 341, 200 and 100 × 10 -7 U/mL for PTK. 100 μL of 20 mg/L PGT (Sigma Aldrich) in 20 mmol/L PBS solution was added to 96-well microtiter plates at 37 °C overnight. After removing excess substrate solution, PBS-Tween 20 (PBST) was used to wash the wells one time, which were dried for 2 h at 37 °C and kept at 4 °C. Subsequently, 50 μL of the above PTK extraction (50 mmol/L HEPES, pH 7.4, 20 mmol/L MgCl 2 , 0.1 mmol/L MnCl 2 , 0.2 mmol/L Na 3 VO 4 , 0.6 mmol/L ATP) was added to the 96-well plates. Then, a certain concentration of the tested compounds (10 μL) and tyrosine kinase tissue extract solution were incubated at 37 °C for 1 h. The plate was washed three times with PBST at the end of the treatment, and 100 μL of the diluted horseradish-peroxidase-labeled mouse anti-phosphotyrosine monoclonal antibody IgG 2bk (Sigma Aldrich) was added to each well, and incubated at 37 °C for 30 min. After removal of the antibody complex, and then washing three times with PBST, 100 μL freshly prepared TMB horseradish peroxidase color development solution (Beijing 4A Biotech Co., Ltd, China) was added and protected
